Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression

Tumour-repopulating cells (TRCs) are a self-renewing, tumorigenic subpopulation of cancer cells critical in cancer progression. However, the underlying mechanisms of how TRCs maintain their self-renewing capability remain elusive. Here we show that relatively undifferentiated melanoma TRCs exhibit plasticity in Cdc42-mediated mechanical stiffening, histone 3 lysine residue 9 (H3K9) methylation, Sox2 expression and self-renewal capability. In contrast to differentiated melanoma cells, TRCs have a low level of H3K9 methylation that is unresponsive to matrix stiffness or applied forces. Silencing H3K9 methyltransferase G9a or SUV39h1 elevates the self-renewal capability of differentiated melanoma cells in a Sox2-dependent manner. Mechanistically, H3K9 methylation at the Sox2 promoter region inhibits Sox2 expression that is essential in maintaining self-renewal and tumorigenicity of TRCs both in vitro and in vivo. Taken together, our data suggest that 3D soft-fibrin-matrix-mediated cell softening, H3K9 demethylation and Sox2 gene expression are essential in regulating TRC self-renewal.

[1]  A. Ting,et al.  Genetically encoded fluorescent reporters of histone methylation in living cells. , 2004, Journal of the American Chemical Society.

[2]  S. Orkin,et al.  Sox2 maintains self-renewal of tumor initiating cells in osteosarcomas , 2011, Oncogene.

[3]  Ravi A. Desai,et al.  Activation of beta 1 but not beta 3 integrin increases cell traction forces , 2013, FEBS letters.

[4]  Ning Wang,et al.  Cytoskeletal mechanics in adherent human airway smooth muscle cells: probe specificity and scaling of protein-protein dynamics. , 2004, American journal of physiology. Cell physiology.

[5]  Falk Wottawah,et al.  Oral cancer diagnosis by mechanical phenotyping. , 2009, Cancer research.

[6]  P. Janmey,et al.  Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[7]  J. Visvader,et al.  Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.

[8]  Ueli Aebi,et al.  The nanomechanical signature of breast cancer. , 2012, Nature nanotechnology.

[9]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[10]  Christopher S. Poultney,et al.  A physical sciences network characterization of non-tumorigenic and metastatic cells , 2013, Scientific Reports.

[11]  S. Kang,et al.  SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC , 2011, Cell Death and Differentiation.

[12]  H. Kato,et al.  G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. , 2002, Genes & development.

[13]  Jun Yao,et al.  G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. , 2012, The Journal of clinical investigation.

[14]  M. Koch,et al.  Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. , 2011, Cell stem cell.

[15]  Manfred Jung,et al.  New lysine methyltransferase drug targets in cancer , 2012, Nature Biotechnology.

[16]  Hans Clevers,et al.  Actomyosin-Mediated Cellular Tension Drives Increased Tissue Stiffness and β-Catenin Activation to Induce Epidermal Hyperplasia and Tumor Growth. , 2024, Cancer cell.

[17]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[18]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[19]  P. Laird,et al.  Epigenetic stem cell signature in cancer , 2007, Nature Genetics.

[20]  Y. Jeng,et al.  H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. , 2012, Cancer research.

[21]  Kristi A. Hohenstein,et al.  Regulation of Self‐Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells , 2008, Stem cells.

[22]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[23]  Richard Superfine,et al.  Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus , 2014, Nature Cell Biology.

[24]  U. Suter,et al.  Sox2 and Mitf cross-regulatory interactions consolidate progenitor and melanocyte lineages in the cranial neural crest , 2012, Development.

[25]  J. van Rheenen,et al.  Brief Report: Intravital Imaging of Cancer Stem Cell Plasticity in Mammary Tumors , 2012, Stem cells.

[26]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[27]  J. Alcaraz,et al.  Collective epithelial cell invasion overcomes mechanical barriers of collagenous extracellular matrix by a narrow tube-like geometry and MMP14-dependent local softening. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[28]  V. Hearing,et al.  Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome‐specific and proteolytically released protein , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Byungkyu Kim,et al.  Cell Stiffness Is a Biomarker of the Metastatic Potential of Ovarian Cancer Cells , 2012, PloS one.

[30]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[31]  Hans Clevers,et al.  Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.

[32]  Christoph Ballestrem,et al.  Marching at the front and dragging behind , 2001, The Journal of cell biology.

[33]  B. Bernstein,et al.  Epigenetic Reprogramming in Cancer , 2013, Science.

[34]  A. Lakshmikuttyamma,et al.  Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition , 2010, Oncogene.

[35]  D. Lang,et al.  Pigmentation PAX‐ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease , 2008, Pigment cell & melanoma research.

[36]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[37]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[38]  R. Janknecht,et al.  KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. , 2013, Cancer research.

[39]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .

[40]  David J. Mooney,et al.  Growth Factors, Matrices, and Forces Combine and Control Stem Cells , 2009, Science.

[41]  Stefan Schinkinger,et al.  Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. , 2005, Biophysical journal.

[42]  A. Rosenberg,et al.  In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma. , 2012, Cancer cell.

[43]  D E Ingber,et al.  Mechanotransduction across the cell surface and through the cytoskeleton. , 1993, Science.

[44]  Benjamin D. Simons,et al.  Defining the mode of tumour growth by clonal analysis , 2012, Nature.

[45]  Chi Wang,et al.  Interaction with Suv39H1 is Critical for Snail-mediated E-cadherin Repression in Breast Cancer , 2012, Oncogene.

[46]  S. Morrison,et al.  Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.

[47]  Ning Wang,et al.  Soft Substrates Promote Homogeneous Self-Renewal of Embryonic Stem Cells via Downregulating Cell-Matrix Tractions , 2010, PloS one.

[48]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[49]  K. Nakayama,et al.  KDM7 is a dual demethylase for histone H3 Lys 9 and Lys 27 and functions in brain development. , 2010, Genes & development.

[50]  J. Rao,et al.  Nanomechanical analysis of cells from cancer patients. , 2007, Nature nanotechnology.

[51]  Jing Liu,et al.  Soft fibrin gels promote selection and growth of tumourigenic cells , 2012, Nature Materials.

[52]  S. Armstrong,et al.  Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML. , 2012, Cell stem cell.

[53]  Paolo Malatesta,et al.  SOX2 Silencing in Glioblastoma Tumor‐Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity , 2009, Stem cells.

[54]  K. Hochedlinger,et al.  The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. , 2013, Cell stem cell.

[55]  Fei Liu,et al.  Micro-Mechanical Characterization of Lung Tissue Using Atomic Force Microscopy , 2011, Journal of visualized experiments : JoVE.